CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Indonesia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Indonesia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2016, Indonesia population was approximately at 258.7 million. Indonesia’s pharmaceutical market is one of the fastest-growing markets in the world and the largest market in the Association of Southeast Nations (ASEAN). It increased at a Compound Annual Growth Rate (CAGR) of 10.3% from IDR33.9 trillion ($3.13 billion) in 2009 to IDR67.2 trillion ($6.20 billion) in 2016, accounting for 27% of the ASEAN pharmaceutical market. The growth was driven by the government’s Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN) and improved macroeconomic conditions. The market is expected to reach IDR109.6 trillion ($10.11 billion) in 2021. The medical device market of Indonesia was worth $2.28 billion in 2016 and is expected to reach $2.83 billion in 2017 and $3.54 billion in 2018.

These positive trends can primarily be attributed to:

Increasing awareness regarding early disease detection and diagnosis

Advances in medical technology

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market (Kalbe Farma, Tempo Scan, Kimia Farma, DaryaVaria and IndoFarma)

An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Indonesian healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in the Indoensian healthcare market

Table of Contents

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData ...

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of the Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Imports and Exports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview Drug Classes

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Reimbursement and Payer Landscape

5.1.1 Overview of Healthcare System

5.1.2 Drug Classifications

5.1.3 Drug Reimbursement Process

5.1.4 Overview of Insurance Providers

5.1.5 Patient Share in Healthcare Spending

5.1.6 Price Trend in Healthcare Services

5.1.7 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 Market Authorization Procedure for New Drugs

5.2.3 Market Authorization Procedure for Medical Devices

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Licensing Process for Pharmaceutical Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Advertising Regulations

5.2.9 Pharmacy Regulations

5.2.10 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Analysis of the Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 General Government Structural Balance

6.3.9 General Government Gross Debt

6.3.10 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Urban–Rural Share

6.4.3 Distribution by Age Group

6.4.4 Birth Rate

6.4.5 Mortality

6.4.6 Causes of Mortality

6.4.7 Health Status by Gender and Age

6.4.8 Education and Literacy

6.4.9 Employment

6.4.10 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Public–Private Sector Share

6.6.3 Major Components of Healthcare Spending

6.7 Trade Associations

6.7.1 International Pharmaceutical Manufacturers Group

6.7.2 Indonesia Pharmaceutical Association

6.7.3 Indonesian Medical Association

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List of tables

Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical Market, Indonesia, Pharmaceutical ...

Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017–2021

Table 3: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009–2016

Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014

Table 5: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009–2015

Table 6: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009–2015

Table 7: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009–2015

Table 8: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009–2015

Table 9: Pharmaceutical Market, Kalbe Farma, Indonesia, Major Products, 2016

Table 10: Pharmaceutical Market, Tempo Scan, Major Products, 2017

Table 11: Pharmaceutical Market, Darya Varia, Major Products, 2017

Table 12: Pharmaceutical Market, Indofarma, Major Products, 2017

Table 13: Market Access, Indonesia, JKN Coverage Population (million), 2017

Table 14: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009–2015

Table 15: Market Access, Indonesia, Healthcare Inflation (%), 2009–2016

Table 16: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009–2016

Table 17: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017–2021

Table 18: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009–2016

Table 19: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Table 20: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009–2016

Table 21: Economic Indicators, Indonesia, Average Consumer Price Index, 2009–2016

Table 22: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009–2016

Table 23: Economic Indicators, Indonesia, Currency Exchange Rate (CAD per $), 2009–2016

Table 24: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009–2016

Table 25: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009–2016

Table 26: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009–2016

Table 27: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009–2016

Table 28: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009–2016

Table 29: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009–2016

Table 30: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016

Table 31: Demographics, Indonesia, Population (million), 2009–2016

Table 32: Demographics, Indonesia, Population (million), 2017–2021

Table 33: Demographics, Indonesia, Urban–Rural Population Share (%), 2009–2016

Table 34: Demographics, Indonesia, Population Distribution by Age Group (%), 2009–2016

Table 35: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017–2021

Table 36: Demographics, Indonesia, Births (per 1,000 population), 2009–2016

Table 37: Demographics, Indonesia, Mortality (per 1,000 population), 2009–2015

Table 38: Demographics, Indonesia, Major Causes of Mortality (‘000), 2015

Table 39: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009–2016

Table 40: Demographics, Indonesia, Immunization Rate (%), 2009–2016

Table 41: Demographics, Indonesia, Major Causes of Male Mortality (‘000), 2015

Table 42: Demographics, Indonesia, Major Causes of Female Mortality (‘000), 2015

Table 43: Demographics, Indonesia, Gender Ratio (M/F), 2009–2015

Table 44: Demographics, Indonesia, Life Expectancy at Birth (years), 2009–2016

Table 45: Demographics, Indonesia, Illiteracy by Age Group (%), 2009–2016

Table 46: Demographics, Indonesia, School Enrollment by Age Group (%), 2015

Table 47: Demographics, Indonesia, Unemployment Rate (%), 2009–2016

Table 48: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease (‘000), 2015

Table 49: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009–2016

Table 50: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009–2016

Table 51: Healthcare Infrastructure, Indonesia, Share of Hospitals by Type of Care, 2015

Table 52: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009–2016

Table 53: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009–2015

Table 54: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009–2015

Table 55: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009–2015

Table 56: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009–2015

Table 57: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009–2015

Table 58: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009–2015

Table 59: Healthcare Expenditure, Indonesia, Public–Private Share (%), 2009–2015

Table 60: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015

Table 61: Healthcare Expenditure, Indonesia, Major Healthcare Trade Fairs, 2017

List of figures

Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2021

Figure 2: Country Profile, Indonesia, 2017

Figure 3: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2016

Figure ...

Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2021

Figure 2: Country Profile, Indonesia, 2017

Figure 3: Pharmaceutical Market, Indonesia, Revenue ($bn), 2009–2016

Figure 4: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2017–2021

Figure 5: Pharmaceutical Market, Indonesia, Pharmaceutical Exports and Imports ($bn), 2009–2016

Figure 6: Pharmaceutical Market, Indonesia, Distribution Chain, 2014

Figure 7: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014

Figure 8: Pharmaceutical Market, Indonesia, Unbranded Generics, Revenue ($m), 2009–2015

Figure 9: Pharmaceutical Market, Indonesia, Unbranded Generics as Percentage of Total Pharmaceutical Market (%), 2009–2015

Figure 10: Pharmaceutical Market, Indonesia, Over-the-Counter Drug Market Revenue ($bn), 2009–2015

Figure 11: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2009–2015

Figure 12: Pharmaceutical Market, Indonesia, Drivers and Barriers, 2017

Figure 13: Market Access, Indonesia, Healthcare System, 2017

Figure 14: Market Access, Indonesia, History of Health Insurance System, 2017

Figure 15: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2015

Figure 16: Market Access, Indonesia, Registration Procedure for JKN, 2017

Figure 17: Market Access, Indonesia, Members of the JKN, 2017

Figure 18: Market Access, Indonesia, Contributions to BPJS, 2017

Figure 19: Market Access, Indonesia, Out-of-Pocket Expenditure as Percentage of Total Health Expenditure (%), 2009–2015

Figure 20: Market Access, Indonesia, Healthcare Inflation (%), 2009–2016

Figure 21: Market Access, Indonesia, Structure of the National Agency of Drug and Food Control, 2017

Figure 22: Market Access, Indonesia, New Drug Application Procedure, 2017

Figure 23: Market Access, Indonesia, Drug Registration Procedure, 2017

Figure 24: Market Access, Indonesia, Drug Evaluation and Decision Making Pathway, 2017

Figure 25: Market Access, Indonesia, Regulatory Framework on Ensuring Quality, Safety and Efficacy of Medicine, 2017

Figure 26: Market Access, Indonesia, Policy for Biosimilar Product Evaluation, 2017

Figure 27: Market Access, Indonesia, General Guidelines on Evaluation of Biosimilar Products, 2017

Figure 28: Market Access, Indonesia, Registration of Biosimilar Products, 2017

Figure 29: Market Access, Indonesia, Medical Device Approval Process, 2017

Figure 30: Market Access, Indonesia, Licensing Process for Manufacturing, 2017

Figure 31: Market Access, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2017

Figure 32: Market Access, Indonesia, Patent Approval Process, 2017

Figure 33: Market Access, Indonesia, Clinical Trial Regulation Process, 2017

Figure 34: Economic Indicators, Indonesia, Gross Domestic Product per Capita ($), 2009–2016

Figure 35: Economic Indicators, Indonesia, Gross Domestic Product per Capita Forecast ($), 2017–2021

Figure 36: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth (%), 2009–2016

Figure 37: Economic Indicators, Indonesia, Gross Domestic Product Annual Growth Forecast (%), 2017–2021

Figure 38: Economic Indicators, Indonesia, Gross National Income per Capita ($), 2009–2016

Figure 39: Economic Indicators, Indonesia, Average Consumer Price Index, 2009–2016

Figure 40: Economic Indicators, Indonesia, Average Consumer Price Annual Change (%), 2009–2016

Figure 41: Economic Indicators, Indonesia, Currency Exchange Rate (CAD per $), 2009–2016

Figure 42: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2009–2016

Figure 43: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2009–2016

Figure 44: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2009–2016

Figure 45: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2009–2016

Figure 46: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2009–2016

Figure 47: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2009–2016

Figure 48: Economic Indicators, Indonesia, Major Industries by Gross Value Added (percentage of GDP), 2016

Figure 49: Demographics, Indonesia, Population (million), 2009–2016

Figure 50: Demographics, Indonesia, Population (million), 2017–2021

Figure 51: Demographics, Indonesia, Urban–Rural Population Share (%), 2009–2016

Figure 52: Demographics, Indonesia, Population Distribution by Age Group (%), 2009–2016

Figure 53: Demographics, Indonesia, Population Distribution by Age Group Forecast (%), 2017–2021

Figure 54: Demographics, Indonesia, Births (per 1,000 population), 2009–2016

Figure 55: Demographics, Indonesia, Mortality (per 1,000 population), 2009–2015

Figure 56: Demographics, Indonesia, Major Causes of Mortality (‘000), 2015

Figure 57: Demographics, Indonesia, Infant Mortality (per 1,000 live births), 2009–2016

Figure 58: Demographics, Indonesia, Immunization Rate (%), 2009–2016

Figure 59: Demographics, Indonesia, Major Causes of Male Mortality (‘000), 2015

Figure 60: Demographics, Indonesia, Major Causes of Female Mortality (‘000), 2015

Figure 61: Demographics, Indonesia, Gender Ratio (M/F), 2009–2015

Figure 62: Demographics, Indonesia, Life Expectancy at Birth (years), 2009–2016

Figure 63: Demographics, Indonesia, Illiteracy by Age Group (%), 2009–2016

Figure 64: Demographics, Indonesia, School Enrollment by Age Group (%), 2015

Figure 65: Demographics, Indonesia, Unemployment Rate (%), 2009–2016

Figure 66: Demographics, Indonesia, Disability-Adjusted Life Years by Major Disease (‘000), 2015

Figure 67: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2009–2016

Figure 68: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 population), 2009–2016

Figure 69: Healthcare Infrastructure, Indonesia, Health Centers (per 100,000 population), 2009–2016

Figure 70: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 1,000 population), 2009–2016

Figure 71: Healthcare Infrastructure, Indonesia, PM2.5 (µg per m3), 2009–2015

Figure 72: Healthcare Infrastructure, Indonesia, CO2 Emissions (million metric tons), 2009–2015

Figure 73: Healthcare Infrastructure, Indonesia, Physicians (per 100,000 population), 2009–2015

Figure 74: Healthcare Infrastructure, Indonesia, Dentists (per 100,000 population), 2009–2015

Figure 75: Healthcare Infrastructure, Indonesia, Nurses (per 100,000 population), 2009–2015

Figure 76: Healthcare Expenditure, Indonesia, Healthcare Expenditure as Percentage of GDP (%), 2009–2015

Figure 77: Healthcare Expenditure, Indonesia, Public–Private Share (%), 2009–2015

Figure 78: Healthcare Expenditure, Indonesia, Major Components of Healthcare Spending (%), 2015

Figure 79: Healthcare Market, Indonesia, Opportunities and Challenges, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports

GlobalData has been instrumental in ensuring we are well informed about our clients business, their key products

  Deloitte Switzerland